These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 28920142)

  • 1. Acupuncture for reduction of symptom burden in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation: a randomized sham-controlled trial.
    Deng G; Giralt S; Chung DJ; Landau H; Siman J; Search B; Coleton M; Vertosick E; Shapiro N; Chien C; Wang XS; Cassileth B; Mao JJ
    Support Care Cancer; 2018 Feb; 26(2):657-665. PubMed ID: 28920142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acupuncture for reduction of symptom burden in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation: a randomized sham-controlled trial. Respond to author.
    Zhang K; Gao C; Tang Q
    Support Care Cancer; 2019 Sep; 27(9):3171-3172. PubMed ID: 30868268
    [No Abstract]   [Full Text] [Related]  

  • 3. Acupuncture improves certain aspects of sleep in hematopoietic stem cell transplantation patients: a secondary analysis of a randomized controlled trial.
    El Iskandarani S; Sun L; Li SQ; Pereira G; Giralt S; Deng G
    Acupunct Med; 2023 Dec; 41(6):319-326. PubMed ID: 37409464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of Opioid Use by Acupuncture in Patients Undergoing Hematopoietic Stem Cell Transplantation: Secondary Analysis of a Randomized, Sham-Controlled Trial.
    Deng G; Giralt S; Chung DJ; Landau H; Siman J; Li QS; Lapen K; Mao JJ
    Pain Med; 2020 Mar; 21(3):636-642. PubMed ID: 31498394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acupuncture As a Potential Opioid-Sparing Pain Management Intervention for Patients Undergoing Cancer Treatment.
    Deng G
    Med Acupunct; 2020 Dec; 32(6):394-395. PubMed ID: 33362896
    [No Abstract]   [Full Text] [Related]  

  • 6. Fractionated stem cell infusions for patients with plasma cell myeloma undergoing autologous hematopoietic cell transplantation.
    Landau H; Wood K; Chung DJ; Koehne G; Lendvai N; Hassoun H; Lesokhin A; Hoover E; Zheng J; Devlin SM; Giralt S
    Leuk Lymphoma; 2016 Aug; 57(8):1781-5. PubMed ID: 26758672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptom burden after autologous stem cell transplantation for multiple myeloma.
    Campagnaro E; Saliba R; Giralt S; Roden L; Mendoza F; Aleman A; Cleeland C; Weber D; Brown J; Anderson KO
    Cancer; 2008 Apr; 112(7):1617-24. PubMed ID: 18260091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher Stem Cell Dose Infusion after Intensive Chemotherapy Does Not Improve Symptom Burden in Older Patients with Multiple Myeloma and Amyloidosis.
    Shah N; Shi Q; Williams LA; Mendoza TR; Wang XS; Reuben JM; Dougherty PM; Bashir Q; Qazilbash MH; Champlin RE; Cleeland CS; Giralt SA
    Biol Blood Marrow Transplant; 2016 Feb; 22(2):226-231. PubMed ID: 26253006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot Trial of Homebound Hematopoietic Cell Transplantation.
    Landau HJ; Orlando E; Rodriguez ES; Applebaum A; Mitchell HR; Peled JU; Khan N; Funnell T; Chung D; Scordo M; Shah GL; LeStrange NJ; Hambright KA; McElrath CM; Cazeau N; Devlin SM; Perales MA; Giralt SA
    Transplant Cell Ther; 2022 Dec; 28(12):832.e1-832.e7. PubMed ID: 36182105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptom experience of multiple myeloma (syMMex) patients treated with autologous stem cell transplantation following high-dose melphalan: a descriptive longitudinal study.
    Naegele M; Kirsch M; Ihorst G; Fierz K; Engelhardt M; De Geest S
    Support Care Cancer; 2018 Mar; 26(3):833-841. PubMed ID: 28918604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of dysgeusia and related symptoms in patients with multiple myeloma after autologous hematopoietic cell transplantation.
    Scordo M; Shah GL; Adintori PA; Knezevic A; Devlin SM; Buchan ML; Preston EV; Lin AP; Rodriguez NT; Carino CA; Nguyen LK; Sitner NC; Barasch A; Klang MG; Maloy MA; Mastrogiacomo B; Carlow DC; Schofield RC; Slingerland AE; Slingerland JB; Stein-Thoeringer CK; Lahoud OB; Landau HJ; Chung DJ; van den Brink MRM; Peled JU; Giralt SA
    Cancer; 2022 Nov; 128(21):3850-3859. PubMed ID: 36041227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory markers and development of symptom burden in patients with multiple myeloma during autologous stem cell transplantation.
    Wang XS; Shi Q; Shah ND; Heijnen CJ; Cohen EN; Reuben JM; Orlowski RZ; Qazilbash MH; Johnson VE; Williams LA; Mendoza TR; Cleeland CS
    Clin Cancer Res; 2014 Mar; 20(5):1366-74. PubMed ID: 24423611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Music Therapy for Symptom Management After Autologous Stem Cell Transplantation: Results From a Randomized Study.
    Bates D; Bolwell B; Majhail NS; Rybicki L; Yurch M; Abounader D; Kohuth J; Jarancik S; Koniarczyk H; McLellan L; Dabney J; Lawrence C; Gallagher L; Kalaycio M; Sobecks R; Dean R; Hill B; Pohlman B; Hamilton BK; Gerds AT; Jagadeesh D; Liu HD
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1567-1572. PubMed ID: 28533058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of a patient-reported outcome in measuring functional impairment during autologous stem cell transplant in patients with multiple myeloma.
    Shah N; Shi Q; Giralt S; Williams L; Bashir Q; Qazilbash M; Champlin RE; Cleeland CS; Wang XS
    Qual Life Res; 2018 Apr; 27(4):979-985. PubMed ID: 29260444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies to improve the outcome of stem cell transplantation in multiple myeloma.
    Catley L; Anderson K
    Hematol J; 2004; 5(1):9-23. PubMed ID: 14745425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trajectories of quality of life recovery and symptom burden after autologous hematopoietic cell transplantation in multiple myeloma.
    D'Souza A; Brazauskas R; Stadtmauer EA; Pasquini MC; Hari P; Bashey A; Callander N; Devine S; Efebera Y; Ganguly S; Gasparetto C; Geller N; Horowitz MM; Koreth J; Landau H; Brunstein C; McCarthy P; Qazilbash MH; Giralt S; Krishnan A; Flynn KE
    Am J Hematol; 2023 Jan; 98(1):140-147. PubMed ID: 35567778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Inpatient Palliative Care on Quality of Life 2 Weeks After Hematopoietic Stem Cell Transplantation: A Randomized Clinical Trial.
    El-Jawahri A; LeBlanc T; VanDusen H; Traeger L; Greer JA; Pirl WF; Jackson VA; Telles J; Rhodes A; Spitzer TR; McAfee S; Chen YA; Lee SS; Temel JS
    JAMA; 2016 Nov; 316(20):2094-2103. PubMed ID: 27893130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aprepitant, granisetron, and dexamethasone for prevention of chemotherapy-induced nausea and vomiting after high-dose melphalan in autologous transplantation for multiple myeloma: results of a randomized, placebo-controlled phase III trial.
    Schmitt T; Goldschmidt H; Neben K; Freiberger A; Hüsing J; Gronkowski M; Thalheimer M; Pelzl le H; Mikus G; Burhenne J; Ho AD; Egerer G
    J Clin Oncol; 2014 Oct; 32(30):3413-20. PubMed ID: 25225424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amifostine reduces gastro-intestinal toxicity after autologous transplantation for multiple myeloma.
    Malek E; Gupta V; Creger R; Caimi P; Vatsayan A; Covut F; Bashir Q; Champlin R; Delgado R; Rondon G; Cooper B; de Lima M; Lazarus HM; Qazilbash M
    Leuk Lymphoma; 2018 Aug; 59(8):1905-1912. PubMed ID: 29295650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of high-dose chemotherapy in the treatment of multiple myeloma: a controversy.
    Kyle RA
    Ann Oncol; 2000; 11 Suppl 1():55-8. PubMed ID: 10707780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.